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SUMM A R Y
We performed genetic and immunohistochemical studies in a sister and brother with 
autosomal recessive neonatal inflammatory skin and bowel lesions. The girl died 
suddenly at 12 years of age from parvovirus B19–associated myocarditis; her brother 
had mild cardiomyopathy. We identified a loss-of-function mutation in ADAM17, 
which encodes a disintegrin and metalloproteinase 17 (also called tumor necrosis 
factor α [TNF-α]–converting enzyme, or TACE), as the probable cause of this syn-
drome. Peripheral-blood mononuclear cells (PBMCs) obtained from the brother at 
17 years of age showed high levels of lipopolysaccharide-induced production of 
interleukin-1β and interleukin-6 but impaired release of TNF-α. Despite repeated 
skin infections, this young man has led a relatively normal life. (Funded by Barts and 
the London Charity and the European Commission Seventh Framework Programme.)
Inflammatory disorders of the skin and gut, including eczema, psoriasis, and celiac disease, have been linked to changes in barrier function and immune responses, by means of genetic and functional studies. Large case–
control studies combined with genomewide association studies have identified com-
mon genetic risk factors, with low penetrance, for a plethora of human disorders. 
Such studies have also identified numerous single-nucleotide polymorphisms (SNPs) 
in genes linked to the regulation of immunity and inflammation affecting epithelial 
tissues.1,2
High-throughput sequence technology can be used to identify rare but penetrant 
disease-associated mutations in affected members of families with mendelian condi-
tions.3-6 We combined this technology with SNP-homozygosity mapping and targeted 
sequence capture to identify likely causative genes in a syndrome of neonatal-onset 
inflammatory skin and bowel disease in two siblings.
C A SE R EPORT
Two of three children born to consanguineous parents (first cousins) of Lebanese 
origin had the same clinical features involving the skin, hair, and gut. The skin lesions 
developed on the second day of life, with diarrhea developing in the first week of life. 
The affected girl died at 12 years of age from fulminant parvovirus B19–associated 
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myocarditis, and on subsequent investigation, the 
affected boy was found to have left ventricular dila-
tation. The skin lesions were perioral and perianal 
erythemas with fissuring and a generalized pustu-
lar rash that developed into psoriasiform erythro-
derma, with flares of erythema, scaling, and wide-
spread pustules (Fig. 1A, 1B, and 1C). The skin of 
both children, when they were young, was prone to 
infection with Staphylococcus aureus, resulting in re-
current blepharitis and otitis externa. Their hair 
was short or broken, and their eyelashes and eye-
brows were wiry and disorganized. They had thick-
ened nails, with frequent paronychia caused by can-
dida and pseudomonas infections.
The chronic diarrhea in the affected girl was 
associated, at 4 months of age, with failure to 
thrive. The diarrhea was predominantly bloody 
with malabsorptive characteristics, worsening in 
parallel with increases in the severity of the skin 
disease and exacerbated by intercurrent gastroin-
testinal infections. Further details of the clinical 
history can be found in the Supplementary Appen-
dix (available with the full text of this article at 
NEJM.org).
ME THODS
Study Participants
We obtained written informed consent from the 
family members and controls. Skin samples were 
obtained from family members as well as control 
patients undergoing cosmetic (facelift or “tummy 
tuck”) surgery, and blood specimens for collection 
of PBMCs were obtained from family members and 
healthy controls.
SNP Mapping, Sequence Capture,  
and Sequencing
The methods used for SNP-homozygosity mapping 
and targeted next-generation sequencing of the re-
gions of linkage are described in the Supplementa-
ry Appendix.
Protein Expression in Skin and Small 
Intestine
We isolated primary keratinocytes from skin-biopsy 
specimens for Western blotting and carried out im-
munofluorescence staining on frozen or paraffin-
embedded tissue sections from biopsy samples of 
skin and small intestine from the affected siblings 
and controls. Details of the antibodies and meth-
ods are given in the Supplementary Appendix.
Immunologic Investigations
We isolated and cultured PBMCs from the affected 
boy, his unaffected mother, and three age-matched 
controls. We measured cytokine levels in cell-cul-
ture supernatants after stimulation with the use of 
cytokine-specific enzyme-linked immunosorbent 
assay kits. Full details of the immunologic studies 
are given in the Supplementary Appendix.
R esult s
Genetic Analyses
Analysis of the SNP array data revealed putative 
linkage (maximum lod score of 1.8) to three large 
stretches of SNP homozygosity, seen in DNA from 
both affected siblings, on chromosomes 2, 5, and 
21 (Fig. 1 in the Supplementary Appendix). After 
ruling out nine plausible candidate genes by using 
standard Sanger sequencing (data not shown), we 
included probes for all exons from these three re-
gions of the genome on a capture array. A total of 
1468 exons corresponding to 439 kb of DNA were 
captured in the affected boy and sequenced. After 
ruling out known SNPs, we identified 22 nonsyn-
onymous single-nucleotide variants in coding re-
gions. In parallel, we assessed the sequence data 
for insertion–deletion variations and discovered a 
new deletion of 4 bp in exon 5 of ADAM17 (c.603–
606delCAGA) on chromosome 2 that segregated 
with the disease in this family (Fig. 1D, and Fig. 2A 
in the Supplementary Appendix). The unaffected 
brother lacked this deletion. We were unable to find 
rare variants, predicted to result in loss of function, 
within ADAM17 in the dbSNP database or the 1000 
Genomes database. Bioinformatic analysis predict-
ed that the mutation would introduce a frame shift 
and a premature stop codon (p.Asp201GlufsX11) 
separated by 10 codons. Thus, the mutation pre-
dicts a severely truncated protein consisting of the 
signal peptide and prodomain of ADAM17 and 
lacking the catalytic domain, disintegrin domain, 
transmembrane segment, and cytosolic tail (Fig. 2B 
in the Supplementary Appendix).
Protein Expression and Cytokine Production
Histochemical analysis of skin specimens from 
an unaffected, unrelated control, with the use of 
an antibody that recognizes the prodomain of 
ADAM17, showed expression throughout the epi-
dermis, with a cytoplasmic distribution (Fig. 2A). 
However, there was a paucity of ADAM17 expres-
sion in skin from the affected boy (Fig. 2B). In 
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addition, immunofluorescence analysis of biopsy 
specimens from the small intestine in both affected 
children revealed a paucity of ADAM17 expression 
(Fig. 2I and 2J). Western blotting of both PBMCs 
and keratinocyte lysates obtained from the affected 
boy showed an absence of ADAM17 expression, in 
contrast with the findings in the healthy controls 
and the unaffected mother (Fig. 2N, and Fig. 3 in 
the Supplementary Appendix). However, the ex-
pression of ADAM10, whose substrates overlap 
with those of ADAM17, was similar in keratino-
cytes from our patient and from a control patient 
undergoing cosmetic surgery (Fig. 4 in the Supple-
mentary Appendix).
Sheddase enzymes cleave and thereby release 
many membrane-bound substrates, including des-
mogleins (DSGs), from the cell surface. Immuno-
fluorescence analysis of skin sections and Western 
blotting of primary keratinocytes showed that 
expression of DSG (DSG1, DSG2, or both) was 
greater in the affected boy than in an unaffected, 
unrelated control (Fig. 3A, 3B, and 3C), suggesting 
that DSG is retained on the plasma membrane. We 
cultured keratinocytes in medium containing fetal-
calf serum, which is known to greatly decrease 
expression of DSG1.7 Therefore, although the anti-
body used recognizes both DSG1 and DSG2, we 
assume it detected mainly DSG2.
ADAM17 also converts membrane-bound 
TNF-α into soluble TNF-α. Bearing in mind the 
inflammatory aspect of the disease phenotype, we 
investigated cytokine production by PBMCs. Stimu-
lation by lipopolysaccharide (Fig. 3D) or anti-CD3 
and anti-CD28 antibodies (Fig. 3E) evoked strong 
and concentration-dependent TNF-α production in 
PMBCs from controls and from the patient’s unaf-
fected mother, with a smaller increase in TNF-α 
production in the PBMCs from the affected boy. 
PBMCs from all samples showed similarly robust 
production of interleukin-1β and interleukin-6 af-
ter lipopolysaccharide stimulation (Fig. 3D) and 
high levels of interferon-γ production after stimu-
lation with anti-CD3 and anti-CD28 antibodies 
(Fig. 3E) (also see the Statistical Analysis section in 
the Supplementary Appendix). Shedding of trans-
membrane proteins on immune cells has been 
shown to be stimulated by activators of protein 
kinase C, such as phorbol 12-myristate 13-acetate 
(PMA).8 In response to PMA and ionomycin (Fig. 
3F), large quantities of interferon-γ were secreted 
by PBMCs from the affected boy, his mother, and 
controls, whereas TNF-α production by PBMCs 
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Figure 1. Clinical Features of the Syndrome and Results of Genetic Analyses in the Study Family.
The affected boy is shown at 5 years of age, with facial erythema and scaling, short scalp hair, and disorganized, 
wiry eyebrows (Panel A); widespread pustules and erythema (Panel B); and swelling of the distal phalanges, ab-
normal nails, and a susceptibility to paronychia (Panel C). The family pedigree shows the two affected siblings and 
their unaffected brother from a consanguineous marriage of first cousins; segregation of the c.603–606delCAGA 
ADAM17 mutation is also shown (Panel D). Squares and circles represent male and female family members, respec-
tively; double horizontal lines indicate consanguinity; solid symbols and open symbols indicate affected and unaf-
fected family members, respectively; and the slash indicates the deceased girl.
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was weak in the boy but strong in the controls and 
the unaffected mother.
Further immunohistochemical characterization 
showed an infiltrate of T cells (CD3+) around the 
skin follicles and in the epithelium. We observed 
CD4+ T cells in the perifollicular region and CD8+ 
T cells in the epithelium at the neck of the fol-
licle (Fig. 5 in the Supplementary Appendix). There 
were very few B cells (CD20+), natural killer cells 
(CD56+), or neutrophils (elastase-positive) present, 
and levels of dendritic cells (S100-positive) were 
within normal limits (data not shown). Of the 
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Figure 2. Expression of ADAM17 in the Skin and Small 
Intestine.
Immunofluorescence staining with the use of an 
ADAM17 antibody (green) that reacts with an epitope 
in the active site of ADAM17 (consisting of a cysteine 
switch and furin cleavage sites) was performed in 
paraffin-embedded sections of biopsy samples of skin 
and small intestine from the affected boy and controls. 
ADAM17 is expressed throughout the epidermis, with 
a cytoplasmic staining pattern, in normal skin (Panel 
A), whereas expression is clearly reduced in the boy’s 
skin (Panel B). Negative-control immunostaining with-
out ADAM17 antibody (blue) was performed on sec-
tions of normal skin (Panel C) and the patient’s skin 
(Panel D). Hematoxylin and eosin staining of biopsy 
specimens of the upper small intestine was performed 
in a control and the two affected siblings. As com-
pared with the normal findings in the control (Panel 
E), there was evidence of a mononuclear-cell infiltrate, 
villus blunting, and lengthening of crypts in the affect-
ed girl (Panel F); although the findings were more vari-
able in the affected boy, there was evidence of a mono-
nuclear-cell infiltrate and villus blunting (Panel G). 
ADAM17 was expressed (green) in the enterocytes of 
the small intestine in a control (Panel H) but was ab-
sent in the small intestine of the affected girl (Panel I) 
and the affected boy (Panel J). Negative-control stain-
ing of the nucleus with 4′,6-diamidino-2-phenylindole 
(DAPI; violet), without the addition of the ADAM17 
antibody, is shown for the control (Panel K), the affect-
ed girl (Panel L), and the affected boy (Panel M). The 
scale bar indicates 250 μm in Panels E through G and 
20 μm in Panels A through D and H through M. West-
ern blotting of ADAM17, with the use of an antibody 
that reacts with the C-terminal of ADAM17, in peripher-
al-blood mononuclear cells (PBMCs) and primary hu-
man keratinocyte (hK) lysates shows that ADAM17 
expression is absent in cells from the male patient (P) 
but is present in cells from four normal controls (NC) 
and the boy’s unaffected mother (Un) (Panel N). 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
was used to show equal loading of the protein in all 
samples.
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Figure 3. Characteristics of ADAM17 Substrates in the Study Participants.
Immunofluorescence staining for DSG1 and DSG2 (green) was performed on frozen skin sections obtained from a 
control (Panel A) and the affected boy (Panel B). Nuclei were stained with propidium iodide (red). Western blotting 
for DSG1 and DSG2 was performed on protein lysates obtained from normal human keratinocytes and the male pa-
tient’s keratinocytes (Panel C). Anti–β-actin antibody was used to demonstrate equal loading. We also evaluated 
proinflammatory cytokine production by peripheral-blood mononuclear cells (PBMCs) from the male patient, his 
unaffected mother, and three healthy controls (HCs) (Panels D, E, and F). Production of tumor necrosis factor α 
(TNF-α), interleukin-1β, and interleukin-6 by PBMCs cultured for 24 hours in lipopolysaccharide (LPS) at concen-
trations of 0.1 to 1000 ng per milliliter was measured to test monocyte activation (Panel D). Also measured was 
the production of TNF-α and interferon-γ (IFN-γ) by PBMCs cultured for 24 hours in the presence or absence of 
 anti-CD3 antibody and anti-CD28 antibody at 1 μg per milliliter, to test T-cell activation (Panel E). Finally, we mea-
sured the production of TNF-α and IFN-γ by PBMCs cultured for 24 hours in the presence or absence of phorbol 
12-myristate 13-acetate (PMA), at 100 ng per milliliter, plus ionomycin at 500 ng per milliliter (Panel F). Cytokine 
levels were measured in cell-culture supernatants by means of an enzyme-linked immunosorbent assay. The data 
are representative of two separate experiments in both Panel D and Panel E.
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skin-barrier proteins assessed, only transgluta-
minase 1 showed reduced expression in the skin 
of the affected boy (Fig. 6 in the Supplementary 
Appendix).
Discussion
We suggest that the deletion mutation in ADAM17 
that was present in the homozygous state in both 
affected children caused their disease. The muta-
tion is predicted to result in a protein that lacks all 
functional domains, including the catalytic domain 
required for the sheddase function of ADAM17.
The mouse orthologue of ADAM17 was knocked 
out in mice over a decade ago, with most mutant 
mice dying before or soon after birth.8 A few mice 
survived for some weeks after birth but had eye 
degeneration, altered hair, and impaired epithelial-
cell maturation in multiple organs, including the 
intestine.8 This extensively abnormal phenotype 
has been attributed to the effects of ADAM17 not 
only on the membrane-bound form of TNF-α but 
also on a plethora of other molecules, including 
transforming growth factor α (TGF-α) and epider-
mal growth factor (EGF).8 Indeed, the hair and 
epithelial defects observed in mice lacking 
Adam17 are similar to those reported in mice 
lacking TGF-α or EGF receptor.9-11
Although there are some similarities between 
the phenotypes of the children we describe here 
and the mutant mice, particularly in relation to the 
hair,8,12 it appears that humans have mechanisms 
that compensate for the lack of ADAM17. In the 
two affected children, we observed a marked re-
duction of ADAM17 expression in the skin and 
small intestine, and although both children had 
skin and gut problems, one child developed nor-
mally until the age of 12 years and the other re-
mains healthy. Two of the most striking features of 
mice lacking Adam17 are the hypoplastic crypts in 
the small bowel and the very low rate of epithelial 
production, which are almost certainly due to the 
fact that ADAM17 is needed to cleave the epithelial-
cell mitogen, TGF-α, from the cell membrane.9,10 
Both children had early-onset diarrhea, which may 
have an origin similar to that of the diarrhea in 
mice lacking Adam17. However, later in life, biopsy 
revealed that the intestines of the affected children 
were substantially normal. This finding also sup-
ports the presence in humans of compensatory 
mechanisms or tethered ligand sufficient to main-
tain the intestinal epithelial renewal in the absence 
of ADAM17. The cause of the gut problems in both 
children has never been satisfactorily resolved and 
requires more investigation.
The affected boy’s keratinocytes expressed 
ADAM10, which cleaves some of the same sub-
strates as ADAM17.13 Desmoglein 2, expressed in 
the less-differentiated layers of the epidermis and 
hair follicle, has been shown to be a direct target 
of both ADAM17 and ADAM10.14 The increase in 
DSG2 expression that we observed in the boy’s 
skin and keratinocytes suggests that ADAM17 
regulation of DSG2 availability at cell junctions is 
important in these tissues.15 DSG2 is the predomi-
nant desmoglein expressed in cardiac myocytes, 
and DSG2 mutations are associated with arrhyth-
mogenic and dilated cardiomyopathies.16,17 The 
relationship between myocarditis and possible 
early-onset arrhythmogenic cardiomyopathy is well 
recognized,18 and impaired DSG2 regulation by 
ADAM17 may be responsible for the cardiac mani-
festations in the affected siblings. In addition, the 
lack of TNF-α may have been partly responsible for 
the affected girl’s death, given the cardioprotective 
role of the molecule in acute myocarditis.19
PBMCs from the affected boy had impaired 
TNF-α production after stimulation with lipopoly-
saccharide, phorbol 12-myristate 13-acetate, or 
anti-CD3 and anti-CD28 antibodies, probably as a 
consequence of the ADAM17 mutation. The low 
level of TNF-α in these cells is most likely due to 
molecules such as ADAM10. The scant production 
of TNF-α may have been a determinant of the af-
fected boy’s increased susceptibility to opportunis-
tic infections of the skin, such as otitis externa 
from S. aureus and paronychia from candida. Given 
the redundancy in the immune system, however, 
other pathways were probably operating in the 
patient’s skin and gut to limit infection and in-
flammation. The observation of marked T-cell 
infiltration in affected areas of the skin, in the 
absence of an acute inflammatory response, is 
consistent with this hypothesis.
It seems reasonable to conclude that the dis-
ease seen in the two siblings we studied is due to 
functional ablation of ADAM17. This enzyme is a 
highly attractive drug target for the treatment of 
chronic inflammatory diseases resulting from ex-
cess TNF-α production.20,21 However, the dramatic 
phenotype affecting the gut, lung, eyes, and hair of 
mice with Adam17 deficiency has dampened en-
thusiasm for this therapeutic approach in humans. 
Our study suggests that loss of ADAM17 is not 
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incompatible with human survival. Perhaps it 
would be worthwhile to re-examine ADAM17 as a 
therapeutic target in patients with chronic diseases 
such as psoriasis, rheumatoid arthritis, and cancer, 
with the understanding that ADAM17 inhibitors 
may have deleterious effects, including hair loss, 
cardiomyopathy, and myocarditis. However, fur-
ther studies are needed to determine whether 
short-term inhibition of the ADAM17 pathway has 
effects similar to those observed in the absence of 
the pathway in our patients.
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